Publications
5532 Results
- Journal / Conference
- Int J Radiat Oncol Biol Phys 39(2):138(#8)
- Year
- 1997
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9340 (RTOG-9404)
Phase III randomized study of radiotherapy plus PCV with or without BUdR for the treatment of anaplastic astrocytoma RTOG 9404 interim report
- Journal / Conference
- Proc of the Society for Neuro-Oncology, booklet:112
- Year
- 1997
- Research Committee(s)
- Brain
- Study Number(s)
- SWOG-9340 (RTOG-9404)
Phase III randomized study of radiotherapy plus PCV with or without BUdR for the treatment of anaplastic astrocytoma: RTOG 9404
- Journal / Conference
- In: Principles of Urologic Oncology, (eds.) Lange P, Raghavan D, Scher H., J.B. Lippincott, Inc., Philadelphia, 1997
- Year
- 1997
- Research Committee(s)
- Genitourinary
Watchful Waiting for Localized Prostate Cancer
- Journal / Conference
- Blood 88(8):2841-2851
- Year
- 1996
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-8600
A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: A Southwest Oncology Group study.
- Journal / Conference
- Investigational New Drugs 14:419-421
- Year
- 1996
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- SWOG-8734
Phase II trial of low-dose N-(phosphonacetyl)-disodium L-aspartic acid and high-dose 24-hour infusional 5-fluorouracil in advanced gastric adenocarcinoma: A Southwest Oncology Group study.
- Journal / Conference
- Urology 47(5):652-657
- Year
- 1996
- Research Committee(s)
- Genitourinary
- Study Number(s)
- SWOG-8704
Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: A Phase I/II Southwestern Oncology Group study.
- Journal / Conference
- Society of Gynecologic Oncologists Abstract Book (#1):40
- Year
- 1996
- Research Committee(s)
- Gynecologic
- Study Number(s)
- SWOG-8501 (INT-0051)
Phase III study of IP cisplatin plus IV cyclophosphamide vs IV cisplatin plus IV cyclophosphamide in optimal disease stage III ovarian cancer: An Intergroup study 0051 (SWOG-GOG-ECOG).
- Journal / Conference
- Journal of Clinical Oncology 14(3):974-977
- Year
- 1996
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-8229/30
Evaluation of race as a prognostic factor in multiple myeloma: An ancillary of Southwest Oncology Group study 8829.
- Journal / Conference
- American Journal of Clinical Oncology 19(2):108-113
- Year
- 1996
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-8921
The addition of tamoxifen to dacarbazine and cisplatin in metastatic malignant melanoma. A phase II trial of the Southwest Oncology Group (SWOG-8921).
- Journal / Conference
- Cancer 78(5):998-1003
- Year
- 1996
- Research Committee(s)
- Lung
- Study Number(s)
- SWOG-9127